Pharmaceutical Science & Technology

Herbs for Diabetes and Neurological Disease Management
Research and Advancements

Editors: Vikas Kumar, PhD, MPharm
Addepalli Veeranjaneyulu, PhD

Herbs for Diabetes and Neurological Disease Management

Published. Available now.
Pub Date: November 2017
Hardback Price: $159.95 US | £124.00
Hard ISBN: 9781771885881
E-Book ISBN: 9781315207575
Pages: 336 pp w/Index
Binding Type: hardback
Notes: 10 color and 11 b/w illustrations

“Our societies find themselves burdened with a growing number of CNS disorders and diabetes, and augmentation of the present therapies by incorporating medicines from natural sources is desirable. Dr. Veeranjaneyulu and Dr. Kumar deserve kudos for putting together this book of thoughtful reviews on plants for treatment of major disorders of central nervous systems and diabetes. Written by several scientists, this book thus fulfills the need for a quick reference and will certainly rekindle interest in this area. . . . This book will be of immense value to researchers in the area and I congratulate both editors.”
—From the Foreword by Dr. Madhu Dikshit, FNA, FASc, FNASc, JC Bose National Fellow/Director, CSIR-Central Drug Research Institute, India

“A valuable guide for modern drug hunters and pharmaceutical industries interested in identification of novel pharmacological therapies for meeting the treatment needs of patients suffering from, or at risk of, diabetes and other non-communicable diseases. Information summarized in this book will certainly be very useful in translating the knowledge and knowhow of practitioners of traditionally known systems of medicine in terms of modern molecular sciences. . . . It cannot be overemphasized that such publications are necessary for evolution of experimental evidence-based holistic medicine.”
—Dr. Shyam Sunder Chatterjee, Retired Head of Pharmacology Research Laboratories; Dr. Willmar Schwabe GMBH & Co.KG, Karlsruhe, Germany

This new volume provides a plethora of new information about potential medicinal herbs and their usefulness in treating diabetes and neurological diseases. Most large multinational companies are interested and engaged in the commercialization of herb-based formulations, and consumers continue to seek natural-based therapies.

Herbs for Diabetes and Neurological Disease Management provides insight into plant-based novel molecules targeted for diabetes and neurological disorders. It looks at a selection of herbs that have proven effective in the management of diabetes and neurological disorders. Divided into ten chapters focusing on diabetes and its macro- and microvascular complications (migraine, epilepsy, memory disorders, depression and other neuropsychiatric disorders), this book is structured to provide a source of reliable information and enrich the knowledge of readers. Each chapter briefly explains the epidemiology and pathophysiology of the disease state and the possible role of herbal drugs in the prevention of the particular disease. The reported pharmacological activities and possible mechanism of action of herbal drugs are also discussed in detail, which makes this book informative and unique.

This new volume will be a reliable reference complementing the substantial information on the use of herbal drugs in diabetes and neurological disorders that serve as the pillars of drug discovery and development.

Key features:

  • offers an overview of role of St.-John’s Wort in the management of diabetes and neurological disorders
  • covers the potential of natural products in the treatment of memory disorders
  • details the phytoconstituents and their potential for anticonvulsant activity in established animal models of epilepsy
  • explores the pivotal role of herbal drugs in neuropsychiatric illnesses
  • explores the role of herbal drugs in the treatment of migraine
  • considers natural products in the development of current anti-diabetic drugs
  • details various herbal drugs as effective treatment options for depression
  • discusses the medicinal herbs used for prevention and maintenance of diabetes and neurodegenerative diseases

Foreword by Dr. Madhu Dikshit, FNA, FASc, FNASc, JC Bose National Fellow/Director, CSIR-Central Drug Research Institute, India


1. Role of St.-John’s Wort (Hypericum perforatum L.) in the Management of Diabetes and Neurological Disorders
Yusuf Ozturk K., Ozgur Devrim Can, and Umide Demir-Ozkay

2. A Potential Natural Product Combination Targeting Memory Disorders
Manju Bhaskar, Meena Chintamaneni, and Veeranjaneyulu Addepalli

3. Phytotherapeutic Agents in Epilepsy
Alka Bali

4. Herbal Medicines in Neuropsychiatric Illness: The Case of L-Stepholidine
Nitin Sati, Kedar S. Prabhavalker, Sridhar N., and Lokesh K Bhatt

5. Potential of Curcuma longa and Withania Somnifera for Diabetes and Associated Neurological Comorbidities
Suruchi Verma, Amitabha Dey, and Vikas Kumar

6. Migraine: Management and Treatment with Herbal Drugs
D. K. Arulmozhi, Yogesh A. Kulkarni, Addepalli Veeranjaneyulu, and R. S. Gaud

7. Complications of Diabetes and Role of a Citrus Flavonoid Nobiletin in Its Treatment
L. K. Bhatt, N. A. Parkar, V. Addepalli, and R. S. Gaud

8. Diabetes and Phytopharmaceuticals: Translational Pharmacology Perspective
Priyanka Ingle-Jadhav, Trupti R. Angolkar, and Ginpreet Kaur

9. Natural Products as Effective Treatment Option for Depression
Yogesh A. Kulkarni, Kalyani H. Barve, and Ginpreet Kaur

10. Medicinal Plants Research
Mila Emerald and David Marrero

About the Authors / Editors:
Editors: Vikas Kumar, PhD, MPharm
Research and Product Development, National Center for Natural Products Research (NCNPR), School of Pharmacy, University of Mississippi, USA

Vikas Kumar, PhD, is currently working in research and product development at the National Center for Natural Products Research (NCNPR), School of Pharmacy, at the University of Mississippi. He was formerly an Innovation Specialist at DD Innovations, Inc., Edina, Minnesota, USA, and Associate Professor of Pharmacology at the Neuropharmacology Research Laboratory, Department of Pharmaceutics, at the Indian Institute of Technology (Banaras Hindu University) in Uttar Pradesh, India. He has published more than 150 papers in peer-reviewed journals as well as four books and eight book chapters. He has visited Canada, Germany, France, China, Nepal, Thailand, Singapore, South Africa, Italy and UAE to enhance his professional experience at various capacities. He is life member of several professional associations and serves as a member of editorial boards of many peer-reviewed international journals. He previously worked successfully and productively in the pharmaceutical industries viz. Lupin Research Park, Pune, and Indian Herbs Research & Supply Co. Ltd., Saharanpur, India. Based on his research findings, Indian Herbs Ltd. successfully launched a product viz. MoodOn® (as a herbal antidepressant and mood enhancer) into the Indian market in collaboration with Bergen Healthcare, a division of Alkem Laboratories Ltd., Mumbai. Currently, MoodOn® is sold under trade name EnMood® ( He also has scientific collaborations with Dr. Willmar Schwabe GmbH & Co. KG, Germany. Dr. Kumar has received Sami Khatib Gold Medal for being a topper in B.Pharm. and Servier Young Investigators’ Award instituted by Institutet de Researches Internationales Servier, France. He is also recipient of the coveted institutional and globally reputed Rashtriya Gaurav Award in 2011 for his achievements in the field of science and technology. Dr. Kumar has obtained his PhD degree from IIT (BHU), Varanasi in 2001 after completing MPharm and BPharm from Gulbarga University in 1997 and 1995 respectively.

Addepalli Veeranjaneyulu, PhD
Associate Dean, Senior Professor, and Head of Pharmacology, SPP School of Pharmacy and Technology Management (SPTM), SVKM’s NMIMS, Mumbai, India

Addepalli Veeranjaneyulu, PhD, is presently serving as Associate Dean and Senior Professor and Head of Pharmacology at SPP, the School of Pharmacy and Technology Management (SPTM), NMIMS, Mumbai, India. He was formerly a Visiting Scientist/Professor at the International Institute of Medical Sciences in China (from 2006-07) under the auspices of the Canadian Heart Foundation. Dr. Addepalli has 16 years of industrial new drug discovery research experience, with over six years as Assistant Director (Pharmacology and Quality Assurance) at NCER, at Lupin Research Park, Pune, India, and over ten years as Research Executive (Pharmacology and Pharmacokinetics) in IDPL R&D, Hyderabad, India. He has 18 years of teaching experience. His research interests are cardiovascular dysfunction and other complications in diabetes; receptor pharmacology; serotonergic receptors; and modulatory roles in migraine, psychosis, and other CNS disorders. He was the Principal Investigator for several projects funded by CSIR, UGC, AICTE, and pharma industrial/academia collaborative projects funded by various pharma companies. He is a member of several national and international professional bodies and is an editorial board member and reviewer for several journals. Dr. Addepalli has over 180 research publications in national and international journals with three industrial patents to his credit. He also presented papers at international and national conferences and seminars and also chaired scientific sessions.

Follow us for the latest from Apple Academic Press:
Copyright © 2018 Apple Academic Press Inc. All Rights Reserved.